- About Us
- Career Center
- Nano-Social Network
- Nano Consulting
- My Account
January 3rd, 2008
Investor Spotlight: Golden Pine Ventures
Golden Pine Ventures, founded in the summer of 2004, has not disclosed the size of its fund, but Meldrum says it has enough to do between six and eight investments in the early-stage biotechnology and biomedical companies it favors.
Meldrum says the firm's typical investment depends on the opportunity, but has invested $100,000 in a couple. "We're looking at opportunities where we want to get to proof of concept," he says.
As an example, he cites the firm's only non-Southeastern investment in Kylin, which employs a revolutionary RNA nanoparticle technology platform called "pRNA" to exploit the enormous potential of RNA interference (RNAi) for treatment of many common diseases.
|Related News Press|
News and information
Nanospiked bacteria are the brightest hard X-ray emitters July 2nd, 2015
Engineering the world’s smallest nanocrystal July 2nd, 2015
Producing spin-entangled electrons July 2nd, 2015
Chivalrous Knight Does Pro Bono June 27th, 2015
Exagan Raises €5.7 Million to Produce High-efficiency GaN-on-Silicon Power-switching Devices on 200mm Wafers: Leti-and-Soitec Spinout Focused on Becoming Leading European Source Of GaN Devices for Solar, Automotive, Telecoms and Infrastructure June 25th, 2015
Interviews/Book Reviews/Essays/Reports/Podcasts/Journals/White papers
The quantum middle man July 2nd, 2015